We are live on
!
Find out more
Clearstead Advisors Portfolio holdings
AUM
$10.6B
Turnover
42.91%
1-Year Est. Return
24.87%
This Fund
S&P 500
This Quarter
Est. Return
+2.37%
1 Year Est. Return
+24.87%
3 Year Est. Return
+71.44%
5 Year Est. Return
+80.35%
10 Year Est. Return
–
AUM
$7.93B
AUM Growth
+$314M
(+4.1%)
Cap. Flow
+$949M
Cap. Flow
% of AUM
11.97%
Top 10 Holdings %
Top 10 Hldgs %
31.01%
Holding
3,334
New
245
Increased
1,176
Reduced
923
Closed
594
Avg Time Held Equity + Options
2.5
years
Top 10 Avg Time Held Equity + Options
3.3
years
Top 20 Avg Time Held Equity + Options
2.9
years
Avg Time Held Equity only
2.5
years
Top 10 Avg Time Held Equity only
3.4
years
Top 20 Avg Time Held Equity only
2.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$727M |
| 2 |
Invesco BulletShares 2033 Corporate Bond ETF
BSCX
|
+$32.2M |
| 3 |
Meta Platforms (Facebook)
META
|
+$19.7M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$14.3M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$13.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
|
+$29.8M |
| 2 |
iShares iBonds Dec 2026 Term Muni Bond ETF
IBMO
|
+$10.7M |
| 3 |
Zoetis
ZTS
|
+$9.85M |
| 4 |
Fiserv Inc
FISV
|
+$7.63M |
| 5 |
Norfolk Southern
NSC
|
+$4.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 60.1% |
| 2 | Technology | 12.05% |
| 3 | Financials | 6.74% |
| 4 | Industrials | 4.89% |
| 5 | Healthcare | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
CVS Health
CVS
$118B
| $2.83M | 0.04% |
35,606
-874
| -2% | -$68.9K |
2016 Q4
36 quarters
|
|
277
iShares Gold Trust
IAU
$61.9B
| $2.82M | 0.04% |
34,693
+1,932
| +6% | +$151K |
2016 Q4
36 quarters
|
|
278
DELISTED
Warner Bros
WBD
| $2.76M | 0.03% |
95,774
+4,360
| +5% | +$102K |
2022 Q2
14 quarters
|
|
279
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
| $2.76M | 0.03% |
52,137
-961
| -2% | -$50.9K |
2024 Q2
6 quarters
|
|
280
Elevance Health
ELV
$92.9B
| $2.75M | 0.03% |
7,849
+96
| +1% | +$32.4K |
2017 Q1
35 quarters
|
|
281
Vanguard Information Technology ETF
VGT
$150B
| $2.73M | 0.03% |
28,968
-1,544
| -5% | -$147K |
2020 Q1
23 quarters
|
|
282
Constellation Energy
CEG
$97.4B
| $2.72M | 0.03% |
7,702
+536
| +7% | +$195K |
2022 Q1
15 quarters
|
|
283
TSMC
TSM
$2.19T
| $2.72M | 0.03% |
8,950
+431
| +5% | +$126K |
2020 Q1
23 quarters
|
|
284
Novartis
NVS
$286B
| $2.64M | 0.03% |
19,130
+112
| +0.6% | +$14.7K |
2016 Q4
36 quarters
|
|
285
Brookfield Infrastructure Partners
BIP
$17.1B
| $2.63M | 0.03% |
75,678
-1,393
| -2% | -$48.5K |
2017 Q3
33 quarters
|
|
286
Calamos Strategic Total Return Fund
CSQ
$3.22B
| $2.6M | 0.03% |
135,419
-2,771
| -2% | -$52.8K |
2024 Q2
6 quarters
|
|
287
FedEx
FDX
$69.9B
| $2.59M | 0.03% |
8,975
+809
| +10% | +$212K |
2017 Q1
35 quarters
|
|
|
288
PUT
Invesco QQQ Trust
QQQ
$487B
| – | – |
0
| – | – |
2025 Q4
0 quarters
|
|
289
iShares Expanded Tech-Software Sector ETF
IGV
$14.6B
| $2.57M | 0.03% |
24,273
+4,945
| +26% | +$544K |
2020 Q1
23 quarters
|
|
290
Amphenol
APH
$201B
| $2.55M | 0.03% |
37,704
-432
| -1% | -$28.9K |
2020 Q1
23 quarters
|
|
291
Martin Marietta Materials
MLM
$34.9B
| $2.54M | 0.03% |
4,086
+182
| +5% | +$113K |
2020 Q1
23 quarters
|
|
292
U.S. Small Cap Portfolio ETF Class Shares
DFAS
$15B
| $2.54M | 0.03% |
36,463
-68
| -0.2% | -$4.69K |
2021 Q2
18 quarters
|
|
293
Royal Bank of Canada
RY
$272B
| $2.53M | 0.03% |
14,863
-1,272
| -8% | -$195K |
2020 Q1
23 quarters
|
|
294
Schwab US Large-Cap Value ETF
SCHV
$15.5B
| $2.53M | 0.03% |
85,324
+2,665
| +3% | +$77.9K |
2020 Q1
23 quarters
|
|
295
Cigna
CI
$79B
| $2.49M | 0.03% |
9,051
+2,209
| +32% | +$619K |
2020 Q1
23 quarters
|
|
296
Vanguard Short-Term Tax-Exempt Bond ETF
VTES
$3.68B
| $2.46M | 0.03% |
24,180
+6,879
| +40% | +$699K |
2024 Q1
7 quarters
|
|
297
VanEck Natural Resources ETF
HAP
$335M
| $2.45M | 0.03% |
40,732
| – | – |
2024 Q4
4 quarters
|
|
298
Vanguard FTSE Europe ETF
VGK
$29.7B
| $2.43M | 0.03% |
29,107
+4,065
| +16% | +$330K |
2020 Q1
23 quarters
|
|
299
KLA
KLAC
$228B
| $2.43M | 0.03% |
19,970
+1,050
| +6% | +$123K |
2020 Q1
23 quarters
|
|
300
KKR & Co
KKR
$78.7B
| $2.42M | 0.03% |
18,985
+2,166
| +13% | +$269K |
2020 Q1
23 quarters
|
|
Similar funds
Clearstead Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Clearstead Advisors held 3,334 positions worth $7.93B, up 4.1% from $7.62B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Clearstead Advisors deployed $949M of net new capital in Q4 2025, opening 245 new positions and adding to 1,176 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 1,170,336 shares worth $734M.
By sector, the portfolio is most concentrated in Miscellaneous at 60% of assets, down from 61% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Invesco BulletShares 2027 Corporate Bond ETF, an estimated $29.8M trimmed.
- Clearstead Advisors's largest Q4 2025 buy was Vanguard S&P 500 ETF: 1,170,336 shares worth $734M.
- Clearstead Advisors added most to Invesco BulletShares 2033 Corporate Bond ETF in Q4 2025, an estimated $32.2M increase.
- Clearstead Advisors's biggest Q4 2025 reduction was Invesco BulletShares 2027 Corporate Bond ETF, cutting an estimated $29.8M.
- Clearstead Advisors fully exited Kellanova in Q4 2025, selling an estimated $2.05M.
- Clearstead Advisors's ten largest holdings make up 31% of its $7.93B portfolio in Q4 2025.
- Clearstead Advisors opened 245 new positions and closed 594 in Q4 2025.
- Clearstead Advisors's portfolio value rose 4.1% quarter-over-quarter to $7.93B.
Based on Clearstead Advisors's 13F filing for Q4 2025, filed 9 Feb 2026.